{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:00:30Z","timestamp":1794362430781,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background: Immunoglobulin derived AL amyloidosis and transthyretin derived ATTR amyloidosis are the most common forms of cardiac amyloidosis. Both may present with cardiac arrhythmias, heart failure, and extracardiac symptoms. Disease outcome is often fatal. Recently, it was proposed that amyloid may cause cardiac inflammation. Here we tested the hypothesis that immune cell infiltration in cardiac tissue correlates with clinicopathological patient characteristics. Patients and methods: Myocardial biopsies from 157 patients with cardiac amyloidosis (46.5% AL, 53.3% ATTR) were immunohistochemically assessed for the presence and amount of T lymphocytes (CD3), macrophages (CD68) and neutrophils (MPO). Amyloid load, cardiomyocyte diameter, apoptosis (Caspase 3), necrosis (complement 9), and various clinical parameters were assessed and correlated with immune cell density. Results: Myocardial tissue was infiltrated with T lymphocytes (CD3), macrophages (CD68) and neutrophils (MPO) with variable amounts. Significant correlations were found between the number of macrophages and NYHA class. No correlations were found between the presence and amount of T lymphocytes, neutrophils and clinicopathological patient characteristics. Conclusion:  The significant correlation between cardiac macrophage density and heart failure points towards a significant role of macrophages in disease pathology.<\/jats:p>","DOI":"10.1038\/s41598-024-74289-5","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:03:11Z","timestamp":1728306191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Myocardial inflammatory cells in cardiac amyloidosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Philip","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Michael","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnt","family":"Kristen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"74289_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.12703\/r\/10-31","volume":"10","author":"P Nijst","year":"2021","unstructured":"Nijst, P. & Tang, W. W. Recent advances in the diagnosis and management of amyloid cardiomyopathy. Fac. Rev. 10, 31 (2021).","journal-title":"Fac. Rev."},{"issue":"1","key":"74289_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms23010025","volume":"23","author":"Y Saito","year":"2021","unstructured":"Saito, Y., Nakamura, K. & Ito, H. Molecular mechanisms of cardiac amyloidosis. Int. J. Mol. Sci. 23 (1), 25 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"74289_CR3","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1161\/CIRCRESAHA.117.310643","volume":"120","author":"R Liao","year":"2017","unstructured":"Liao, R. & Ward, J. E. Amyloid cardiomyopathy: Disease on the rise. Circ. Res. 120 (12), 1865\u20131867 (2017).","journal-title":"Circ. Res."},{"issue":"6","key":"74289_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","volume":"24","author":"JJ Malszewski","year":"2015","unstructured":"Malszewski, J. J. Cardiac amyloidosis: Pathology, nomenclature, and typing. Cardiovasc. Pathol. 24 (6), 343\u2013350 (2015).","journal-title":"Cardiovasc. Pathol."},{"issue":"10038","key":"74289_CR5","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechaleker","year":"2016","unstructured":"Wechaleker, A. D., Gillmore, J. D. & Hawkins, P. N. Systemic amyloidosis. Lancet. 387 (10038), 2641\u20132654 (2016).","journal-title":"Lancet"},{"issue":"2","key":"74289_CR6","first-page":"212","volume":"119","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. & Chaolu, H. Diagnostic role pf NT-proBNP in patients with cardiac amyloidosis involvement: A meta-analysis. Arg Bras. Cardiol. 119 (2), 212\u2013222 (2022).","journal-title":"Arg Bras. Cardiol."},{"issue":"1","key":"74289_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jacc.2016.04.035","volume":"68","author":"AV Kristen","year":"2016","unstructured":"Kristen, A. V. et al. Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis. J. Am. Coll. Cardiol. 68 (1), 13\u201324 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"74289_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","volume":"94","author":"DA Brenner","year":"2004","unstructured":"Brenner, D. A. et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ. Res. 94 (8), 1008\u20131010 (2004).","journal-title":"Circ. Res."},{"issue":"5","key":"74289_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00395-013-0378-5","volume":"108","author":"J Guan","year":"2013","unstructured":"Guan, J. et al. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic. Res. Cardio. 108 (5), 378 (2013).","journal-title":"Basic. Res. Cardio"},{"issue":"9","key":"74289_CR10","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1073\/pnas.0912263107","volume":"107","author":"J Shi","year":"2019","unstructured":"Shi, J. et al. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical MAPK pathway. Proc. Natl. Acad. Sci. 107 (9), 4188\u20134193 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"74289_CR11","doi-asserted-by":"publisher","first-page":"H95","DOI":"10.1152\/ajpheart.00186.2013","volume":"305","author":"S Mishra","year":"2013","unstructured":"Mishra, S. et al. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am. J. Physiol. Heart Circ. Physiol. 305 (1), H95\u2013103 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"14","key":"74289_CR12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","volume":"104","author":"R Liao","year":"2001","unstructured":"Liao, R. et al. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation. 104 (14), 1594\u20131597 (2001).","journal-title":"Circulation"},{"issue":"17","key":"74289_CR13","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","volume":"389","author":"MS Maurer","year":"2023","unstructured":"Maurer, M. S. et al. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl. J. Med. 389 (17), 1553\u20131565 (2023).","journal-title":"N Engl. J. Med."},{"key":"74289_CR14","first-page":"16","volume":"14","author":"MD Benson","year":"2020","unstructured":"Benson, M. D., Dasgupta, N. R. & Rao, R. Diagnosis and screening of patients with hereditary transthyretin amyloidosis (hATTR): current strategies and guidelines. Ther. Clin. Risk Manag. 14, 16 (2020).","journal-title":"Ther. Clin. Risk Manag."},{"issue":"4","key":"74289_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bjh.12286","volume":"161","author":"JH Pinney","year":"2013","unstructured":"Pinney, J. H. et al. Systemic amyloidosis in England: An epidemiological study. Br. J. Haematol. 161 (4), 525\u2013532 (2013).","journal-title":"Br. J. Haematol."},{"issue":"11","key":"74289_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jacc.2019.12.069","volume":"75","author":"JA Chirinos","year":"2020","unstructured":"Chirinos, J. A. et al. Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction. J. Am. Coll. Cardiol. 75 (11), 1281\u20131295 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"74289_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","volume":"8","author":"VS Hahn","year":"2020","unstructured":"Hahn, V. S. et al. Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis. JACC Heart Fail. 8 (9), 712\u2013724 (2020).","journal-title":"JACC Heart Fail."},{"issue":"1","key":"74289_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","volume":"4","author":"D Westermann","year":"2011","unstructured":"Westermann, D. et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ. Heart Fail. 4 (1), 44\u201352 (2011).","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"74289_CR19","first-page":"H552H562","volume":"314","author":"J You","year":"2018","unstructured":"You, J. et al. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload. Am. J. Physiol. Heart Circ. Physiol. 314 (3), H552H562 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"74289_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0002-9149(96)00425-0","volume":"78","author":"G De Simone","year":"1996","unstructured":"De Simone, G. et al. Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. Am. J. Cardiol. 78 (7), 801\u2013807 (1996).","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"74289_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","volume":"108","author":"F Aus dem Siepen","year":"2019","unstructured":"Aus dem Siepen, F. et al. Carpal tunnel syndrome and spinal canal stenosis: Harbingers of transthyretin amyloid cardiomyopathy? Clin. Res. Cardiol. 108 (12), 1324\u20131330 (2019).","journal-title":"Clin. Res. Cardiol."},{"issue":"2","key":"74289_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","volume":"119","author":"SO Sch\u00f6nland","year":"2012","unstructured":"Sch\u00f6nland, S. O. et al. Immunohistochemistry in the classification of systemic forms of amyloidosis: A systematic investigation of 117 patients. Blood. 119 (2), 488\u2013493 (2012).","journal-title":"Blood"},{"issue":"4","key":"74289_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2559.1996.tb01416.x","volume":"29","author":"C R\u00f6cken","year":"1996","unstructured":"R\u00f6cken, C. et al. The classification of amyloid deposits in clinicopathological practice. Histopathology. 29 (4), 325\u2013335 (1996).","journal-title":"Histopathology"},{"issue":"7","key":"74289_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 9 (7), 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"issue":"3","key":"74289_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/13506129.2021.1932799","volume":"28","author":"A Lux","year":"2021","unstructured":"Lux, A. et al. Complement 9 in amyloid deposits. Amyloid. 28 (3), 199\u2013208 (2021).","journal-title":"Amyloid"},{"issue":"6","key":"74289_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10741-012-9355-6","volume":"18","author":"C Basso","year":"2013","unstructured":"Basso, C. et al. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail. Rev. 18 (6), 673\u2013681 (2013).","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"74289_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.recesp.2015.10.018","volume":"69","author":"F Dominguez","year":"2016","unstructured":"Dominguez, F. et al. Update on myocarditis and inflammatory cardiomyopathy: Reemergence of endomyocardial biopsy. Rev. Esp. Cardiol. (Engl Ed). 69 (2), 178\u2013187 (2016).","journal-title":"Rev. Esp. Cardiol. (Engl Ed)"},{"issue":"1","key":"74289_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cell.2020.08.031","volume":"183","author":"JA Nicolas-Avila","year":"2020","unstructured":"Nicolas-Avila, J. A. et al. A network of macrophages supports mitochondrial homeostasis in the heart. Cell. 183 (1), 94\u2013109 (2020).","journal-title":"Cell"},{"issue":"6","key":"74289_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/ndt\/9.6.662","volume":"9","author":"A Argiles","year":"1994","unstructured":"Argiles, A. et al. Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophages. Nephrol. Dial Transpl. 9 (6), 86\u201389 (1994).","journal-title":"Nephrol. Dial Transpl."},{"issue":"2","key":"74289_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1525-139x.2001.00037.x","volume":"14","author":"M Jadoul","year":"2001","unstructured":"Jadoul, M., Garbar, C. & van Ypersele de Strihou, C. Pathological aspects of beta(2)-microglobulin amyloidosis. Semin Dial. 14 (2), 86\u201389 (2001).","journal-title":"Semin Dial"},{"issue":"10","key":"74289_CR31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1440-1827.1999.00962.x","volume":"49","author":"Y Nakamura","year":"1999","unstructured":"Nakamura, Y. et al. A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells. Pathol. Int. 49 (10), 898\u2013902 (1999).","journal-title":"Pathol. Int."},{"issue":"20","key":"74289_CR32","doi-asserted-by":"publisher","first-page":"e020358","DOI":"10.1161\/JAHA.120.020358","volume":"10","author":"A Pucci","year":"2021","unstructured":"Pucci, A. et al. Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis. J. Am. Heart Assoc. 10 (20), e020358 (2021).","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"74289_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","volume":"25","author":"MA Stats","year":"2016","unstructured":"Stats, M. A. & Stone, J. R. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Cardiovasc. Pathol. 25 (5), 413\u2013417 (2016).","journal-title":"Cardiovasc. Pathol."},{"issue":"5","key":"74289_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajpath.2019.01.011","volume":"189","author":"T Richey","year":"2019","unstructured":"Richey, T. et al. Macrophage-mediated phagocytosis and dissolution of amyloid-like fibrils in mice, monitored by optical imaging. Am. J. Pathol. 189 (5), 989\u2013998 (2019).","journal-title":"Am. J. Pathol."},{"issue":"1","key":"74289_CR35","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1038\/s41467-021-23274-x","volume":"12","author":"A Michalon","year":"2021","unstructured":"Michalon, A. et al. A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells. Nat. Commun. 12 (1), 3142 (2021).","journal-title":"Nat. Commun."},{"issue":"4","key":"74289_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ejhf.1039","volume":"20","author":"C Sigismund","year":"2018","unstructured":"Sigismund, C. et al. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis. Eur. J. Heart Fail. 20 (4), 751\u2013757 (2018).","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"74289_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaccao.2020.08.013","volume":"2","author":"TV Kourelis","year":"2020","unstructured":"Kourelis, T. V. et al. A proteomic atlas of cardiac amyloid plaques. JACC CardioOncol. 2 (4), 632\u2013643 (2020).","journal-title":"JACC CardioOncol."},{"issue":"2","key":"74289_CR38","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5858\/134.2.256","volume":"134","author":"CP Jenkins","year":"2010","unstructured":"Jenkins, C. P. et al. The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction. Arch. Pathol. Lab. Med. 134 (2), 256\u2013263 (2010).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"12","key":"74289_CR39","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1021\/pr400583h","volume":"12","author":"F Brambilla","year":"2013","unstructured":"Brambilla, F. et al. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. J. Proteome Res. 12 (12), 5642\u20135655 (2013).","journal-title":"J. Proteome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74289-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74289-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74289-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T15:14:44Z","timestamp":1728573284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74289-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74289"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74289-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23313"}}